Greg Galler
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Epidemiology top 1%
- Microscopic Colitis
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
-
- Hepatitis C virus research 7
-
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Fabrizio Michelassi (1 shared paper)Stephen B. Hanauer (1 shared paper)Asher Kornbluth (1 shared paper)Simon Lichtiger (1 shared paper)Irwin M. Gelernt (1 shared paper)Joel J. Bauer (1 shared paper)D. H. Present (1 shared paper)Jonathan McCone (7 shared papers)
- Journals
- Journal of Hepatology (2 papers)New England Journal of Medicine (2 papers)Hepatology (2 papers)Clinical Infectious Diseases (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesSpainJapan
In The Last Decade
Greg Galler
13 papers receiving 2.3k citations
Greg Galler's Hit Papers
Peers
Comparison fields: 5 of 91
- Hepatology 1.2k
- Epidemiology 1.7k
- Genetics 1.1k
- Gastroenterology 148
- Rheumatology 193
Countries citing papers authored by Greg Galler
This map shows the geographic impact of Greg Galler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Galler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Galler more than expected).
Fields of papers citing papers by Greg Galler
This network shows the impact of papers produced by Greg Galler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Galler. The network helps show where Greg Galler may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Galler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy Hit paper breakdown → | 1994 | 1267 |
| 2 | Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection Hit paper breakdown → | 2009 | 889 |
| 3 | 2007 | 55 | |
| 4 | 2014 | 44 | |
| 5 | 2011 | 36 | |
| 6 | 2008 | 29 | |
| 7 | 2010 | 24 | |
| 8 | 2010 | 21 | |
| 9 | 1996 | 17 | |
| 10 | 2014 | 8 | |
| 11 | Impaired Fasting Glucose Is Associated With Lower Rates of Sustained Virologic Response (SVR) in Patients With Genotype 1 Chronic Hepatitis C (CHC): Retrospective Analysis of the IDEAL Study | 2010 | 2 |
| 12 | Hematologic Safety Data From the IDEAL Trial: Neutropenia, Anemia, and Thrombocytopenia Profiles of Peginterferon alfa/Ribavirin | 2008 | 1 |
| 13 | 2012 | 1 |
About Greg Galler
Greg Galler is a scholar working on Hepatology, Epidemiology, Gastroenterology, Genetics and Physiology, having authored 13 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Gastrointestinal motility and disorders (3 papers), Diet and metabolism studies (2 papers), Inflammatory Bowel Disease (1 paper), Blood groups and transfusion (1 paper) and Blood disorders and treatments (1 paper). The work is most often cited by research in Hepatology (1.2k citations), Epidemiology (1.7k citations), Genetics (1.1k citations), Gastroenterology (148 citations) and Rheumatology (193 citations). Greg Galler has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Fabrizio Michelassi, Stephen B. Hanauer, Asher Kornbluth, Simon Lichtiger, Irwin M. Gelernt, Joel J. Bauer, D. H. Present, Jonathan McCone, Clifford A. Brass and Mark Sulkowski. Their work appears in journals such as Journal of Hepatology, New England Journal of Medicine, Hepatology, Clinical Infectious Diseases and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.